Trinity Biotech | TRIB - Current Assets

Stock Price
0.77
Daily Change
0.07 10.56%
Monthly
0%
Yearly
11.68%
Q1 Forecast
0.74

Trinity Biotech reported $35.52M in Current Assets for its fiscal quarter ending in September of 2025.





Current Assets Change Date
Abbott USD 26B 1.16B Dec/2025
Bayer EUR 32.91B 30M Dec/2025
Bio-Rad Laboratories USD 2.91B 64.2M Dec/2025
EDAP TMS EUR 44.35M 7.13M Sep/2025
J&J USD 55.62B 1.01B Dec/2025
Mesa Laboratories USD 105.63M 8.2M Dec/2025
OraSure Technologies USD 283.01M 18.43M Sep/2025
Plus Therapeutics USD 9.83M 1.75M Dec/2023
Roche Holding CHF 38.73B 3.03B Dec/2025
Siemens EUR 67.91B 3.2B Dec/2025
Surmodics USD 81.3M 948K Sep/2024
Thermo Fisher Scientific USD 28.71B 6.41B Dec/2025
Tosoh JPY 759.27B 28.26B Dec/2025
Trinity Biotech USD 35.52M 2.52M Sep/2025
Veracyte USD 488.38M 39.15M Dec/2025